Hopes rise for a new treatment option for people living with lupus, after UCB and Biogen reveal phase 3 data with their anti-CD40L antibody DZP.

EULAR 2025 Methotrexate Boosts Steroid-Free Remission in Early PMR Compared with placebo, adding methotrexate nearly doubled steroid-free remission rates and reduced time to remission by 11 weeks.

UCB and Biogen say their first phase 3 trial of systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, with a second planned.

Find rheumatology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.

EULAR 2025 Methotrexate Boosts Steroid-Free Remission in Early PMR Compared with placebo, adding methotrexate nearly doubled steroid-free remission rates and reduced time to remission by 11 weeks.

Find the latest Tonix Pharmaceuticals Holding Corp. (TNXP) stock quote, history, news and other vital information to help you with your stock trading and investing.